Microplastics and Nanoplastics in Atheromas and Cardiovascular Events
There is no direct evidence that microplastics and nanoplastics are a risk factor for cardiovascular disease in humans.
- True
- False
There is no direct evidence that microplastics and nanoplastics are a risk factor for cardiovascular disease in humans.
Dry powder inhalers produce a smaller carbon footprint than metered dose inhalers when used for asthma maintenance therapy without loss of asthma control.